Immunogen Inc
(IMGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 06-1999 | 12-1998 | 06-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,220 | N/A | 1,740 | 1,740 | 1,669 |
| Other current assets | 1,320 | 0 | 1,920 | 1,920 | 579 |
| TOTAL | $5,540 | $N/A | $3,660 | $3,660 | $2,248 |
| Non-Current Assets | |||||
| PPE Net | 1,580 | N/A | 1,890 | 1,890 | 2,930 |
| Other Non-Current Assets | 40 | 0 | 310 | 310 | 0 |
| TOTAL | $1,620 | $N/A | $2,200 | $2,200 | $2,930 |
| Total Assets | $7,170 | $N/A | $5,870 | $5,870 | $6,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 870 | 0 | 690 | 690 | 0 |
| Accrued Expenses | 810 | N/A | 770 | 770 | N/A |
| Other current liabilities | 0 | N/A | 50 | 50 | N/A |
| TOTAL | $1,770 | $N/A | $1,530 | $1,530 | $1,829 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60 | N/A | 0 | 0 | N/A |
| TOTAL | $60 | $N/A | $30 | $30 | $N/A |
| Total Liabilities | $1,840 | $N/A | $1,560 | $1,560 | $1,829 |
| Shareholders' Equity | |||||
| Common Shares | 250 | N/A | 250 | 250 | 218 |
| Retained earnings | -153,710 | N/A | -148,720 | -148,720 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 4,245 |
| TOTAL | $5,330 | $N/A | $4,310 | $4,310 | $4,463 |
| Total Liabilities And Equity | $7,170 | $0 | $5,870 | $5,870 | $6,292 |